Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00906_DB01264_nanopub.RArKFrIix0hzrRYgjG5MPL9bpcy5nEZOTd_omeACLWcto#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00906_DB01264 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00906_DB01264 label "DDI between Tiagabine and Darunavir - The strong CYP3A4 inhibitor, Darunavir, may decrease the metabolism and clearance of Tiagabine, a CYP3A4 substrate. Consider alternate therapy or monitor for changes in the therapeutic/adverse effects of Tiagabine if Darunavir is initiated, discontinued or dose changed. [drugbank_resource:DB00906_DB01264]" assertion.
- drugbank_resource:DB00906_DB01264 identifier "drugbank_resource:DB00906_DB01264" assertion.
- drugbank_resource:DB00906_DB01264 title "DDI between Tiagabine and Darunavir - The strong CYP3A4 inhibitor, Darunavir, may decrease the metabolism and clearance of Tiagabine, a CYP3A4 substrate. Consider alternate therapy or monitor for changes in the therapeutic/adverse effects of Tiagabine if Darunavir is initiated, discontinued or dose changed." assertion.
- drugbank:DB01264 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00906_DB01264 assertion.
- drugbank:DB00906 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00906_DB01264 assertion.